GT Biopharma (GTBP) Shares Outstanding (Diluted) (2012 - 2026)
GT Biopharma (GTBP) recorded Shares Outstanding (Diluted) of 1.21 million in Q1 2026, compared with 93,803 a year earlier and up 449.3% from the prior quarter.
Powered by 
Analysis
GT Biopharma (GTBP) Shares Outstanding (Diluted) (2012 - 2026) Analysis & Trends
For FY2025, GT Biopharma reported Shares Outstanding (Diluted) of 220,530, up 190.6% from FY2024.
- Annual Shares Outstanding (Diluted) has increased for four straight years, with a five-year compound annual growth rate of 106.7% (FY2020 to FY2025).
- Across earlier years, Shares Outstanding (Diluted) came in at 75,895 in FY2024 (+40.8%), 53,909 in FY2023 (+26.9%), 42,491 in FY2022 (+626.8%) and 5,846 in FY2021 (unchanged).
- The Q1 2026 figure is the highest quarterly Shares Outstanding (Diluted) in data going back to Q1 2012.
- Over the past five years, the year-over-year growth in Shares Outstanding (Diluted) ranged from 0.0% (Q4 2021) to 640.9% (Q1 2023).
- Per Business Quant, the preceding three quarters came in at 220,530 (Q4 2025), 157,629 (Q3 2025) and 110,871 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 893.70 Mn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 2.44 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 1.56 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 544.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 5.70 Bn |
| 10 | GT Biopharma | 8.73 Mn | 8.73 Mn | - | 1.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.21 Mn |
| Dec 31, 2025 | 220,530.00 |
| Sep 30, 2025 | 157,629.00 |
| Jun 30, 2025 | 110,871.00 |
| Mar 31, 2025 | 93,803.00 |
| Dec 31, 2024 | 75,895.00 |
| Sep 30, 2024 | 89,373.00 |
| Jun 30, 2024 | 68,478.00 |
| Mar 31, 2024 | 55,225.00 |
| Dec 31, 2023 | 53,909.00 |
| Sep 30, 2023 | 54,688.00 |
| Jun 30, 2023 | 53,563.00 |
| Mar 31, 2023 | 43,315.00 |
| Dec 31, 2022 | 42,491.00 |
| Sep 30, 2022 | 41,837.00 |
| Jun 30, 2022 | 41,646.00 |
| Mar 31, 2022 | 5,846.00 |
| Dec 31, 2021 | 5,846.00 |
| Sep 30, 2021 | 5,846.00 |
| Jun 30, 2021 | 5,846.00 |
API Access
GT Biopharma Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=GTBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "GTBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=GTBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();